Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen capsule immune modulation in influenza
ChiCTR2100054799Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lianhua Qingwen in influenza (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Immune cell subsets and Inflammatory factors. Started May 2021; status: recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2100054799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054799.